Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Alpha-9 Oncology USA Inc.
Massachusetts General Hospital
Ohio State University
European Organisation for Research and Treatment of Cancer - EORTC
Thomas Jefferson University
MonTa Biosciences ApS
Aura Biosciences
University of Pittsburgh
Aura Biosciences
Immatics US, Inc.
Replimune Inc.
IDEAYA Biosciences
IDEAYA Biosciences
H. Lee Moffitt Cancer Center and Research Institute
OncoNano Medicine, Inc.
Linnaeus Therapeutics, Inc.
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Iovance Biotherapeutics, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Thomas Jefferson University
Novelwise Pharmaceutical Corporation
Modulation Therapeutics, Inc.
Novelty Nobility, Inc.
Institut Curie
St Vincent's Hospital, Sydney
University of Pittsburgh
University of Miami
University of Valencia
St. Erik Eye Hospital
Leiden University Medical Center
Vastra Gotaland Region
Aura Biosciences
Medical University of Vienna
California Pacific Medical Center Research Institute
Hadassah Medical Organization